USPTO serial 79186613
ISK
Reviewed by CopyMark Law Group
Reg. 5173581Status 706Renewal
- Filing date
- Status date
- Registration date
- Apr 4, 2017
- Examiner
- POWERS, ALEXANDER L
- Law office
- GENERIC WEB UPDATE
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ISK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph S. Presta
Joseph S. Presta Nixon & Vanderhye PC901 N. Glebe Rd.11th FloorArlington, VA 22203Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of Anti-inflammatory, [ anti-shock, ] inflammation of digestive system, [ inflammation of respiratory system, ] anti-pancreatitis, [ pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress; ] veterinary preparations for Companion animals, farm animals, dogs [, cats, horses, chickens, cattle and pigs ] for the treatment of Anti-inflammatory, [ anti-shock, ] inflammation of digestive system, [ inflammation of respiratory system, ] anti-pancreatitis, [ pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress; ] pharameutical agents affecting digestive organs; [ pharmaceutical preparations for skin care for animals; pharmaceutical preparations and ] agents, namely, medical test kits composed primarily of reagents and vectors; veterinary preparations and agents, namely, medical test kits composed primarily of reagents and vectors; pharmaceutical preparations and agents, namely, surgical or orthopedic bone cement and medical bone bonding agent; [ veterinary preparations and agents, namely, surgical or orthopedic bone cement and medical bone bonding agent; ] medicines for veterinary purposes for Companion animals, farm animals, dogs [, cats, horses, chickens, cattle and pigs ] for the treatment of Anti-inflammatory, [ anti-shock, ] inflammation of digestive system, [ inflammation of respiratory system, ] anti-pancreatitis [, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ISHIHARA SANGYO KAISHA, LTD.
- Other trademarks owned by ISHIHARA SANGYO KAISHA, LTD.
- Other trademarks owned by ISHIHARA SANGYO KAISHA, LTD.
- Other trademarks in Class 005
- Similar marks named ISK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 4, 2026 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Nov 23, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 18, 2024 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 23, 2024 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 23, 2024 | INPC | INVALIDATION PROCESSED | — |
| Jun 14, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 22, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Mar 22, 2024 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Feb 22, 2024 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Oct 10, 2023 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Oct 5, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 15, 2023 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jun 17, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Apr 4, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 4, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 14, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 14, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 4, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 4, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 16, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 17, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 12, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 28, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 28, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 28, 2016 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 15, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 10, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 10, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 10, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2016 | ALIE | ASSIGNED TO LIE | — |
| Nov 18, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 10, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 23, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 23, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 21, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 20, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 15, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| May 14, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 10, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 9, 2016 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 5, 2016 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |